Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Navient Corp is a credit services business based in the US. Navient shares (NAVI) are listed on the NASDAQ and all prices are listed in US Dollars. Navient employs 4,330 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $14.60 |
|---|---|
| 52-week range | $12.45 - $23.15 |
| 50-day moving average | $15.27 |
| 200-day moving average | $18.31 |
| Wall St. target price | $19.75 |
| PE ratio | 3.6338 |
| Dividend yield | $0.64 (4.54%) |
| Earnings per share (TTM) | $3.85 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $14.6 from 2022-07-05
| 1 week (2022-06-30) | 4.36% |
|---|---|
| 1 month (2022-06-03) | -4.82% |
| 3 months (2022-04-07) | -11.46% |
| 6 months (2022-01-07) | -34.41% |
| 1 year (2021-07-07) | -23.20% |
|---|---|
| 2 years (2020-07-07) | 115.18% |
| 3 years (2019-07-05) | 3.55% |
| 5 years (2017-07-07) | 16.18 |
Valuing Navient stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Navient's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Navient's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Navient shares trade at around 4x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Navient's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.142. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Navient's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $2.1 billion |
|---|---|
| Operating margin TTM | 43.07% |
| Gross profit TTM | $2.3 billion |
| Return on assets TTM | 0.74% |
| Return on equity TTM | 21.63% |
| Profit margin | 29.2% |
| Book value | $18.99 |
| Market capitalisation | $2.1 billion |
TTM: trailing 12 months
Dividend payout ratio: 27.23% of net profits
Recently Navient has paid out, on average, around 27.23% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.54% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Navient shareholders could enjoy a 4.54% return on their shares, in the form of dividend payments. In Navient's case, that would currently equate to about $0.64 per share.
While Navient's payout ratio might seem fairly standard, it's worth remembering that Navient may be investing much of the rest of its net profits in future growth.
Navient's most recent dividend payout was on 16 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 1 June 2022 (the "ex-dividend date").
Over the last 12 months, Navient's shares have ranged in value from as little as $12.45 up to $23.1512. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Navient's is 1.6711. This would suggest that Navient's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Navient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates through three segments: Federal Education Loans, Consumer Lending, and Business Processing. The company owns Federal Family Education Loan Program (FFELP) loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, as well as asset recovery services on FFELP loans owned by other institutions. It also owns, originates, acquires, and services refinance and in-school private education loans; and offers healthcare services that include revenue cycle outsourcing, accounts receivable management, extended business office support, consulting engagement, and public health programs, as well as business processing services to state governments, agencies, court systems, municipalities, and parking and tolling authorities. In addition, the company provides customizable solutions for its clients that include hospitals, hospital systems, medical centers, large physician groups, other healthcare providers, and public health departments; and corporate liquidity portfolio services. Navient Corporation was founded in 1973 and is headquartered in Wilmington, Delaware. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.